Next Generation Cardiometabolic Diagnostics

Zora Biosciences Oy is a diagnostic company with a cardiometabolic focus.

We use mass spectrometry to identify markers of disease and develop them into robust, high-throughput, value-added clinical diagnostic tests which are commercialized together with our international partners or through our own reference laboratory in Finland.

Read more about Zora

Our Diagnostic Tests

1) Heart disease: CERT2 - Ceramide-based cardiovascular risk score for assessing risk of myocardial infarction, cardiovascular death and stroke

2) Type 2 Diabetes: dSCORE - Ceramide-based risk score for the probability of type II diabetes onset

3) Fatty Liver Disease: In development

Zora publications

Please check our latest publications including our research on coronary event risk. The publications can be found from News - Publications.